Greenway Medical Technologies, which provides integrated IT solutions and services to US physicians, will see its quiet period end on 3/13/12. On 2/1/12, the company raised $66.7 million by offering 6,666,667 shares at $10.00, below the range of $11.00 to...read more
In a sign of strong demand, today's two IPOs both priced above the range. Bazaarvoice, which provides an online customer review platform to brands and retailers, ...read more
Bazaarvoice, which provides an online customer review platform to brands and retailers, raised a greater-than-expected $114 million by offering 9,484,296 shares at $12, more than 30% above the midpoint of its proposed $8-$10 price range. Bazaarvoice will begin...read more
For all the positive headlines (the Facebook announcement, the jobs report, the market rally), the end of January was a mixed bag for the US IPO market. The FTSE Renaissance US IPO Index (IPOS), up 15.4% year-to-date, maintained its stellar start to the year,...read more
Greenway Medical Technologies quiet period ends March 13
Greenway Medical Technologies, which provides integrated IT solutions and services to US physicians, will see its quiet period end on 3/13/12. On 2/1/12, the company raised $66.7 million by offering 6,666,667 shares at $10.00, below the range of $11.00 to...read more
Today's two IPOs price above the range
In a sign of strong demand, today's two IPOs both priced above the range. Bazaarvoice, which provides an online customer review platform to brands and retailers, ...read more
Bazaarvoice prices IPO at $12, well above its $8-$10 range
Bazaarvoice, which provides an online customer review platform to brands and retailers, raised a greater-than-expected $114 million by offering 9,484,296 shares at $12, more than 30% above the midpoint of its proposed $8-$10 price range. Bazaarvoice will begin...read more
Troubles for the energy industry detract from exciting week for US IPOs
For all the positive headlines (the Facebook announcement, the jobs report, the market rally), the end of January was a mixed bag for the US IPO market. The FTSE Renaissance US IPO Index (IPOS), up 15.4% year-to-date, maintained its stellar start to the year,...read more